6955 — Shandong Boan Biotechnology Co Balance Sheet
0.000.00%
- HK$6.57bn
- HK$6.72bn
- CNY726.32m
Annual balance sheet for Shandong Boan Biotechnology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 3.63 | 614 | 233 | 202 | 199 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 30.9 | 126 | 227 | 293 | 515 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 92.1 | 940 | 847 | 713 | 956 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 491 | 601 | 624 | 660 | 652 |
| Net Intangible Assets | |||||
| Total Assets | 908 | 2,107 | 2,203 | 2,323 | 2,851 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 396 | 260 | 472 | 653 | 649 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 426 | 555 | 784 | 1,004 | 1,207 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 482 | 1,552 | 1,418 | 1,320 | 1,644 |
| Total Liabilities & Shareholders' Equity | 908 | 2,107 | 2,203 | 2,323 | 2,851 |
| Total Common Shares Outstanding |